Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 14, 2020; 26(30): 4415-4427
Published online Aug 14, 2020. doi: 10.3748/wjg.v26.i30.4415
Published online Aug 14, 2020. doi: 10.3748/wjg.v26.i30.4415
Target area | 2020 target | 2030 target |
Impact targets | ||
Incidence: New cases of chronic HCV | 30% reduction | 80% reduction |
Mortality: HCV related deaths | 10% reduction | 65% reduction |
Service coverage targets | ||
Blood safety: Donations screened in a quality assured manner | 95% | 100% |
Safe injections: Percentage of injections administered with safety-engineered devices in and out of health facilities | 50% | 90% |
Harm reduction: Number of sterile needles and syringes provided per person who injects drugs per year | 200 | 300 |
HCV diagnosis: Percent of people aware of their diagnosis | 30% | 90% |
HCV treatment: Percent of people treated | - | 80% |
- Citation: Hasan F, Alfadhli A, Al-Gharabally A, Alkhaldi M, Colombo M, Lazarus JV. Accelerating the elimination of hepatitis C in Kuwait: An expert opinion. World J Gastroenterol 2020; 26(30): 4415-4427
- URL: https://www.wjgnet.com/1007-9327/full/v26/i30/4415.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i30.4415